HCI Group (HCI) awards CFO 1,251 restricted shares with staged vesting

Rhea-AI Filing Summary

HCI Group, Inc. reported a new equity award to its Chief Financial Officer, James Mark Harmsworth. On 12/19/2025, he received a restricted stock grant of 1,251 shares of common stock under the company’s 2012 Omnibus Incentive Plan. These shares are scheduled to vest in three equal installments of 417 shares on October 23, 2026, October 23, 2027, and October 23, 2028, subject to continued employment.

The filing also notes an earlier restricted stock grant of 34,000 shares effective 2/26/2021, for which vesting conditions have been met and which is scheduled to vest on May 22, 2026, as long as he remains employed by the company. Following the reported transactions, Harmsworth beneficially owns 16,608 shares of common stock directly.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Harmsworth James Mark

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,251	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,251 shares (Direct)

Footnotes (1)

1. Restricted stock grant of 34,000 shares effective 2/26/2021: The restricted shares have previously met the vesting condition and are scheduled to vest on May 22, 2026, as long as the reporting person remains employed by the Issuer. The shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021. Restricted stock grant of 1,251 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harmsworth James Mark

(Last) (First) (Middle)

3802 COCONUT PALM DRIVE

(Street)

TAMPA FL 33619

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HCI Group, Inc. [ HCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								16,608	D
Common Stock								34,000(1)	D
Common Stock	12/19/2025		A		1,251	A	(2)	1,251	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock grant of 34,000 shares effective 2/26/2021: The restricted shares have previously met the vesting condition and are scheduled to vest on May 22, 2026, as long as the reporting person remains employed by the Issuer. The shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.

2. Restricted stock grant of 1,251 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

	/s/ Andrew L. Graham as Attorney-in-fact for James Mark Harmsworth	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HCI (HCI) disclose in this filing?

HCI Group disclosed that its Chief Financial Officer, James Mark Harmsworth, received a restricted stock grant of 1,251 common shares on 12/19/2025 under the 2012 Omnibus Incentive Plan.

How will the new 1,251-share restricted stock grant for HCIs CFO vest?

The 1,251 restricted shares will vest in three equal tranches of 417 shares each on October 23, 2026, October 23, 2027, and October 23, 2028, if the CFO remains employed.

What earlier restricted stock grant to HCIs CFO is referenced in this Form 4?

The filing references a prior restricted stock grant of 34,000 shares effective 2/26/2021, which has met vesting conditions and is scheduled to vest on May 22, 2026, subject to continued employment.

How many HCI Group shares does the CFO beneficially own after the reported transactions?

After the reported transactions, James Mark Harmsworth beneficially owns 16,608 shares of HCI Group common stock directly.

Under what plan were the restricted stock grants to HCIs CFO made?

Both the 34,000-share grant effective 2/26/2021 and the 1,251-share grant effective 12/19/2025 were issued under HCI Groups 2012 Omnibus Incentive Plan pursuant to restricted stock agreements.

What is the CFOs role and relationship to HCI Group, Inc.?

The reporting person, James Mark Harmsworth, is an officer of HCI Group, Inc., serving as its Chief Financial Officer, and he files as a single reporting person on this Form 4.